Stocks
GlaxoSmithKline (GSK) ROA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | 5.54% | 8.18% | 8.18% | 8.35% | 8.35% | 5.49% | ||
| Changes by years, y/y, % | 0pp | +3pp | 0pp | +0pp | 0pp | +6.0% | |||
GlaxoSmithKline. ROA, %
GlaxoSmithKline. ROA, changes, pp
GlaxoSmithKline (GSK) ROA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| ROA, % | ? | 9.00% | 9.92% | 8.35% | 8.35% | 7.66% | 5.49% | |
| Changes by years, y/y, % | +4pp | +1pp | 0pp | 0pp | 0pp | |||
| Changes by quarters, q/q, % | 0pp | +1pp | -2pp | 0pp | -1pp | |||
